Of course revenue is good, that ten fold and we may be able to break even. It doesn't mean much still without the valuation of CG. As for solely MM, I don't see much revenue from that so we will wait and see. Mabsut is BS, was touted as 1m last year and I bet we don't see that in three.
Ann: Material Revenues Confirmed from Non-Pharma Business Units, page-104
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RGT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
32.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.48M | |||
| Open | High | Low | Value | Volume |
| 30.0¢ | 32.0¢ | 30.0¢ | $31.45K | 98.95K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4674 | 30.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 36.0¢ | 4326 | 1 |
View Market Depth
| Last trade - 12.44pm 05/09/2024 (20 minute delay) ? |
| RGT (ASX) Chart |